Related Experiment Videos
Echocardiography for primary care evaluation of hypertension
Insights
Echocardiography is a sensitive tool for detecting left ventricular hypertrophy (LVH) in essential hypertension. Limited echocardiograms may increase its role in primary care for specific patients.
Area of Science:
- Cardiology
- Hypertension Research
- Diagnostic Imaging
Background:
- Essential hypertension management guidelines have evolved since 1993.
- Left ventricular hypertrophy (LVH) is a key cardiovascular risk indicator in hypertensive patients.
- Echocardiography offers superior sensitivity for LVH detection compared to electrocardiography (ECG).
Purpose of the Study:
- To re-evaluate the role of echocardiography in primary care for essential hypertension.
- To assess current recommendations and evidence impacting echocardiography use in hypertension management.
Main Methods:
- Review of new recommendations from Canadian and American cardiovascular societies.
- Analysis of evidence from prospective trials, including limited echocardiogram studies.
- Inclusion of data from long-term studies like the Framingham Heart Study.
Main Results:
- Echocardiography remains a sensitive method for detecting LVH, a predictor of cardiovascular events.
- Limited echocardiograms, though less common, are cost-effective for LVH assessment in stage 1 hypertension.
- Technical standards are improving the reliability of echocardiographic measurements.
Conclusions:
- Limited echocardiograms, when used with Canadian technical standards, could expand echocardiography's role in evaluating essential hypertension.
- This approach may aid treatment decisions for select hypertensive patients.
Objective:
To reexamine the changing role of echocardiography for primary care evaluation of essential hypertension since the 1993 Canadian Hypertension Society Consensus Conference.
Quality Of Evidence:
New recommendations from the Canadian Cardiovascular Society and the Canadian Hypertension Society. Recommendations from the American College of Cardiology based on a prospective, randomized controlled trial of limited echocardiograms. Further results from the Framingham Heart Study and the Treatment of Mild Hypertension Study.
Main Message:
For patients with essential hypertension, left ventricular hypertrophy (LVH) continues to be a strong predictor of many cardiovascular end points, and echocardiography is a much more sensitive tool for detecting LVH than electrocardiogram (ECG). Although limited echocardiograms are not usually used, they are a less costly method of evaluating LVH than standard echocardiograms and have recently been recommended in the United States to assist in the decision to initiate pharmacotherapy for patients with stage 1 hypertension and no other evidence of target organ damage. Problems with intrareader and interreader variability of results are being addressed by technical and mathematical standards established by the Canadian Cardiovascular Society and the Canadian Hypertension Society.
Conclusions:
Using limited echocardiograms for assessing LVH coupled with implementing Canadian technical standards might lead to a greater role for echocardiography in evaluating essential hypertension in certain patients.